Evidence map›Paper›PMID 33149794›Full record

ArticlePharmacy practice

Clinical impact of a pharmacist-led medication review with follow up for aged polypharmacy patients: A cluster randomized controlled trial.

Raquel Varas-Doval, Miguel A Gastelurrutia, Shalom I Benrimoj, Victoria García-Cárdenas, Loreto Sáez-Benito, Fernando Martinez-Martínez

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Pharmacy practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05348538 (Feasibility Study of the Medication Review With Follow up Service for Patients With Polypharmacy in Swiss Community Pharmacies), which is not on this map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05348538 naunknown statusnot on this map

Feasibility Study of the Medication Review With Follow up Service for Patients With Polypharmacy in Swiss Community Pharmacies

TypeinterventionalSponsorCenter for Primary Care and Public Health (Unisante), University of Lausanne, SwitzerlandRan2023 to 2024Enrolled162ConditionsChronic DiseaseArmsMedication review with follow up or MaJ? for the acronym in french
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Raquel Varas-DovalM.Pharm, BPharm, Pharmaceutical Services, Department of Innovation and Education, Spanish General Council of Official Pharmacists Associations. Madrid (Spain). raquelvaras@redfarma.org.ORCID https://orcid.org/0000-0002-0666-9739
Miguel A GastelurrutiaPhD, MSc, BPharm. Pharmaceutical Research Group of the University of Granada, Faculty of Pharmacy, University of Granada. Granada (Spain). magastelu@farmanorte.org.ORCID https://orcid.org/0000-0003-1019-0234
Shalom I BenrimojPhD, BPharm (hons). Pharmaceutical Research Group of the University of Granada, Faculty of Pharmacy, University of Granada. Granada (Spain). shalom.benrimoj@gmail.com.ORCID https://orcid.org/0000-0001-9768-7838
Victoria García-CárdenasPhD, MPharm, BPharm. Senior Lecturer, Graduate School of Health, Discipline of Pharmacy University of Technology Sydney. Sydney, NSW (Australia). victoria.garciacardenas@uts.edu.au.ORCID https://orcid.org/0000-0003-3770-4557
Loreto Sáez-BenitoPhD, MPharm. Teaching and Research Academic Staff, Faculty of Health Sciences, San Jorge University. Zaragoza (Spain). lsaezbenito@usj.es.ORCID https://orcid.org/0000-0001-5416-1828
Fernando Martinez-MartínezPhD, BPharm. Professor, Pharmaceutical Research Group of the University of Granada, Faculty of Pharmacy, University of Granada. Granada (Spain). femartin@ugr.es.ORCID https://orcid.org/0000-0001-8247-1751
Universidad de Granada · ESNational Research Council · LKUniversidad San Jorge · ESUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedication review with follow-up (MRF) is a service where community pharmacists undertake a medication review with monthly follow-up to provide continuing care. The ConSIGUE Program assessed the impact and implementation of MRF for aged polypharmacy patients in Spanish Community Pharmacies. The present paper reports on the clinical impact evaluation phase of ConSIGUE.

objectiveThe main objective of the study was to measure the effect of MRF on the primary outcome of the number of uncontrolled health problems. Secondary objectives were to analyze the drug-related problems (DRPs) identified as potential causes of ineffective or unsafe medications and the pharmacists' interventions implemented during MRF provision.

methodsAn open-label multi-centered cluster randomized study with comparison group (CG) was carried out in community pharmacies from 4 provinces in Spain during 6 months. The main inclusion criteria were patients over 64 years old, using 5 or more medicines. The intervention group (IG) received the MRF service (advanced medication review-type 3 MR) whereas patients in the CG received usual care.

results178 pharmacies recruited 1403 patients (IG= 688 patients; CG= 715 patients). During the 6 months of the study 72 patients were lost to follow up. The adjusted multi-level random effects models showed a significant reduction in the number of uncontrolled health problems over the periods in the IG (-0.72, 95% CI: -0.80, -0.65) and no change in the CG (-0.03, 95% CI: -0.10, 0.04). Main DRPs identified as potential causes of failures of uncontrolled health problems' treatment were undertreated condition (559 DRPs; 35.81%), lack of treatment adherence (261 DRP; 16.67%) and risk of adverse effects (207 DRPs; 13.53%). Interventions performed by pharmacist to solve DRP mainly included the addition (246 interventions; 14.67%) and change (330 interventions; 19.68%) of a medicine and educational interventions on medicine adherence (231 interventions; 13.78%) and non-pharmacological interventions (369 interventions; 22.01%).

conclusionsThis study provides evidence of the impact of community pharmacist on clinical outcomes for aged patients. It suggests that the provision of an MRF in collaboration with general medical practitioners and patients contributes to the improvement of aged polypharmacy patients' health status and reduces their problems related with the use of medicines.

Indexed as

Community Pharmacy ServicesMedication Therapy ManagementPharmaciesPharmacistsPolypharmacyRandomized Controlled Trials as TopicSpainTreatment Adherence and Compliance

Identifiers

PMID33149794
PMCPMC7603656
OpenAlexW3094154585

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.